Efficacy and safety of topical antifungals in the treatment of dermatomycosis: a systematic review

@article{Rotta2012EfficacyAS,
  title={Efficacy and safety of topical antifungals in the treatment of dermatomycosis: a systematic review},
  author={Inajara Rotta and A S{\'a}nchez and Patr{\'i}cia Rodrigues Gonçalves and Michel Fleith Otuki and C J Correr},
  journal={British Journal of Dermatology},
  year={2012},
  volume={166}
}
The analysis of comparative efficacy and safety of topical antifungals in the literature is restricted to the treatment of tinea pedis and onychomycosis. [] Key Method Therefore our objective was to evaluate and compare the efficacy and safety of topical antifungals used in the treatment of dermatomycosis, we performed a comprehensive search for randomized controlled trials (RCTs) in the following databases: Medline, Cochrane Central Register of Controlled Trials, EMBASE, Lilacs and International…
Efficacy of topical antifungals in the treatment of dermatophytosis: a mixed-treatment comparison meta-analysis involving 14 treatments.
TLDR
This is the first mixed-treatment comparison meta-analysis on antifungal treatments in the literature and shows all the evidence available at the time of the study, finding butenafine, naftifine, and terbinafine might be the best strategies for maintaining cured status.
Consensus for the Treatment of Tinea Pedis: A Systematic Review of Randomised Controlled Trials
TLDR
Topical terbinafine and butenafine treatments of tinea pedis were more efficacious than placebo and tableted terbINAfine and itraconazole administered orally were efficacious in the drug treatment of t Guinea pedis fungal infection.
Topical antifungal‐corticosteroid combination therapy for the treatment of superficial mycoses: conclusions of an expert panel meeting
TLDR
This review summarises available treatment options for superficial fungal infections and provides general treatment recommendations based on the consensus outcomes of an Expert Panel meeting on the topical treatment of superficial mycoses.
Efficacy of Topical Antifungals in the Treatment of Dermatophytosis A Mixed-Treatment Comparison Meta-analysis Involving 14 Treatments
TLDR
This is the first mixed-treatment comparison meta-analysis on antifungal treatments in the literature and shows all the evidence available at the time of the study.
Naftifine and therapy of fungal skin infections: 40 years of success
TLDR
Taking into consideration a broad range of its action including antifungal, antibacterial and anti-inflammatory effects, Naftifine can be considered as a first-line drug for the treatment of superficial dermatomycoses including complicated with a bacterial infection.
Therapeutic efficacy of topical luliconazole versus topical ketoconazole in the treatment of pityriasis versicolor patients: a hospital based comparative study
TLDR
Male population as well as age 26-35 years were more prone for pityriasis versicolor infection, but, on continue 4 weeks of treatment regimens topical luliconazole had more clinically efficacious than ketoconazole against pityriotic patients.
Evidence‐based topical treatments for tinea cruris and tinea corporis: a summary of a Cochrane systematic review
TLDR
The need for further, high‐quality, adequately powered RCTs to evaluate the effects of topical treatments for tinea cruris and tinea corporis is highlighted, which can ultimately provide reliable evidence to inform clinical decision making.
Newer Topical Treatments in Skin and Nail Dermatophyte Infections
TLDR
The newer formulations or newer derivatives of existing drug classes and few newer drug classes are being developed to tackle the growing epidemic of recurrent/chronic dermatophytosis and cost remained most important obstacle in developing countries like India.
Comparación entre bifonazol y ketoconazol en el tratamiento de tinea pedis: resultados de un ensayo clínico
IntroductIon: Superficial mycoses are among the most frequent causes of consult in dermatology. The comparative efficacy and roll of traditional anti-mycotic drugs needs to be assessed. objetIve: To
Pityriasis versicolor: an update on pharmacological treatment options
TLDR
The absence of standardized collection and reporting practices in clinical trials precludes any conclusions to be drawn regarding the efficacy and safety of topical and systemic agents in comparison or in concert with each other.
...
...

References

SHOWING 1-10 OF 18 REFERENCES
Systematic review of topical treatments for fungal infections of the skin and nails of the feet
TLDR
Topical allylamines—available only on prescription—cure slightly more infections of the skin of the foot than topical azoles or undecenoic acid, both of which are available over the counter No significant differences in efficacy between individual allies or individual azoles were found.
Update in Antifungal Therapy of Dermatophytosis
TLDR
Treatment of dermatophyte infection involves primarily oral and/or topical formulations of azoles or allylamines, particularly itraconazole and terbinafine and their role in the treatment of the different clinical forms of onychomycosis is currently being defined.
Topical treatments for fungal infections of the skin and nails of the foot.
TLDR
The 6 trials of nail infections provided evidence that topical ciclopiroxolamine has poor cure rates and that amorolfine might be substantially more effective but more research is required, and placebo-controlled trials of allylamines and azoles for athlete's foot consistently produce much higher percentages of cure than placebo.
COMPARATIVE EFFICACY OF NAFTIFINE, OXICONAZOLE, AND TERBINAFINE IN SHORT‐TERM TREATMENT OF TINEA PEDIS
The subjects, men ranging m age from 25 to 80 years, were recruited from an ambulatory-care dermatology clinic. The diagnosis of tinea pedis was verified by both a positive KOH preparation and a
Current Management of Fungal Infections
TLDR
In empirical therapy, lipid-associated formulations of amphotericin-B and intravenous itraconazole are safer than, and at least as effective as, conventional amphoteric in-B (the former gold standard).
An Overview of Topical Antifungal Therapy in Dermatomycoses
TLDR
It is important to confirm mycologically the clinical diagnosis of onychomycosis and other tinea infections prior to commencing therapy, and the identity of the fungal organism may provide guidance about the appropriateness of a given topical antifungal agent.
Fungal infections of the skin: infection process and antimycotic therapy.
TLDR
The antifungal agents currently marketed for dermatomycoses are mainly inhibitors of ergosterol biosynthesis, except for griseofulvin, which interferes with the cytoplasmic and nuclear microtubular system.
Fungal infections of skin and nails of feet
TLDR
Hart et al provide purchasers with a more balanced view by presenting the costs of treating patients with an azole initially followed by an allylamine against the likely cost of treating all patients with allylamines from the start.
Dermatophyte infections.
TLDR
Oral therapy is preferred for tinea capitis, tinea barbae, and onychomycosis and "pulse" oral therapy with the newer imidazoles (itraconazole or fluconazole) or allylamines (terbinafine) is considerably less expensive than continuous treatment but has a somewhat lower mycologic cure rate.
An Overview of Fungal Infections
TLDR
Systemic fungal infections may be caused by either an opportunistic organism that infects an at-risk host, or may be associated with a more invasive organism that is endemic to a specific geographical area.
...
...